| __timestamp | Geron Corporation | Pfizer Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 20707000 | 8393000000 |
| Thursday, January 1, 2015 | 17831000 | 7690000000 |
| Friday, January 1, 2016 | 18047000 | 7872000000 |
| Sunday, January 1, 2017 | 11033000 | 7657000000 |
| Monday, January 1, 2018 | 13432000 | 8006000000 |
| Tuesday, January 1, 2019 | 52072000 | 8650000000 |
| Wednesday, January 1, 2020 | 51488000 | 9405000000 |
| Friday, January 1, 2021 | 85727000 | 13829000000 |
| Saturday, January 1, 2022 | 95518000 | 11428000000 |
| Sunday, January 1, 2023 | 125046000 | 10679000000 |
| Monday, January 1, 2024 | 10930000000 |
Unleashing the power of data
In the competitive landscape of pharmaceuticals, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Pfizer Inc. and Geron Corporation have demonstrated contrasting strategies in their R&D investments. From 2014 to 2023, Pfizer's R&D expenses have consistently dwarfed those of Geron, with Pfizer investing nearly 200 times more in 2023 alone. This substantial investment reflects Pfizer's robust pipeline and its strategic focus on maintaining a leading edge in the industry. Meanwhile, Geron has shown a steady increase in its R&D spending, growing by over 500% from 2014 to 2023, signaling its dedication to advancing its niche in oncology. This divergence in R&D spending highlights the varied approaches these companies take in their pursuit of innovation and market leadership.
Comparing Innovation Spending: Pfizer Inc. and Summit Therapeutics Inc.
Pfizer Inc. vs Jazz Pharmaceuticals plc: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Pfizer Inc. and Grifols, S.A.
Comparing Innovation Spending: Pfizer Inc. and Corcept Therapeutics Incorporated
R&D Insights: How Pfizer Inc. and Rhythm Pharmaceuticals, Inc. Allocate Funds
Pfizer Inc. vs Dynavax Technologies Corporation: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Pfizer Inc. and Viridian Therapeutics, Inc.
R&D Insights: How Sanofi and Geron Corporation Allocate Funds
Research and Development: Comparing Key Metrics for Genmab A/S and Geron Corporation
Research and Development Investment: Summit Therapeutics Inc. vs Geron Corporation
Rhythm Pharmaceuticals, Inc. vs Geron Corporation: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: Arrowhead Pharmaceuticals, Inc. vs Geron Corporation